Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Women's Health | 18 | 2023 | 88 | 2.500 |
Why?
|
| Pediatric Obesity | 2 | 2022 | 24 | 1.360 |
Why?
|
| Menopause | 9 | 2022 | 41 | 1.170 |
Why?
|
| Coronary Artery Disease | 4 | 2018 | 56 | 1.040 |
Why?
|
| Calcinosis | 2 | 2016 | 14 | 0.830 |
Why?
|
| Middle Aged | 34 | 2023 | 4043 | 0.790 |
Why?
|
| Postoperative Complications | 4 | 2020 | 385 | 0.760 |
Why?
|
| Sleep | 4 | 2020 | 155 | 0.730 |
Why?
|
| Female | 38 | 2023 | 6974 | 0.690 |
Why?
|
| Coronary Vessels | 3 | 2017 | 17 | 0.690 |
Why?
|
| Humans | 41 | 2023 | 12240 | 0.640 |
Why?
|
| Menopause, Premature | 1 | 2020 | 3 | 0.630 |
Why?
|
| Hysterectomy | 1 | 2020 | 10 | 0.620 |
Why?
|
| Depression | 4 | 2016 | 229 | 0.610 |
Why?
|
| Risk Factors | 19 | 2022 | 1049 | 0.600 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 45 | 0.590 |
Why?
|
| Cardiovascular Diseases | 8 | 2021 | 166 | 0.520 |
Why?
|
| United States | 14 | 2021 | 989 | 0.510 |
Why?
|
| Pain | 2 | 2023 | 193 | 0.500 |
Why?
|
| Metabolic Syndrome | 3 | 2016 | 40 | 0.490 |
Why?
|
| Disease Progression | 4 | 2017 | 290 | 0.490 |
Why?
|
| Adult | 21 | 2023 | 3557 | 0.470 |
Why?
|
| Body Mass Index | 8 | 2021 | 221 | 0.470 |
Why?
|
| Adiposity | 6 | 2018 | 24 | 0.440 |
Why?
|
| Obesity, Abdominal | 4 | 2018 | 11 | 0.420 |
Why?
|
| Longitudinal Studies | 9 | 2022 | 651 | 0.410 |
Why?
|
| Adipose Tissue | 6 | 2022 | 41 | 0.380 |
Why?
|
| Follow-Up Studies | 10 | 2021 | 726 | 0.360 |
Why?
|
| Role | 1 | 2012 | 5 | 0.360 |
Why?
|
| Stress, Psychological | 2 | 2012 | 112 | 0.350 |
Why?
|
| Child | 3 | 2023 | 614 | 0.340 |
Why?
|
| Cohort Studies | 7 | 2020 | 827 | 0.340 |
Why?
|
| Intra-Abdominal Fat | 4 | 2018 | 17 | 0.310 |
Why?
|
| Atherosclerosis | 3 | 2018 | 20 | 0.300 |
Why?
|
| Postmenopause | 2 | 2021 | 26 | 0.290 |
Why?
|
| Coronary Angiography | 3 | 2018 | 30 | 0.290 |
Why?
|
| Vascular Calcification | 2 | 2018 | 5 | 0.270 |
Why?
|
| Insulin Resistance | 2 | 2022 | 19 | 0.260 |
Why?
|
| Cross-Sectional Studies | 7 | 2022 | 400 | 0.250 |
Why?
|
| Odds Ratio | 5 | 2016 | 115 | 0.240 |
Why?
|
| Retrospective Studies | 7 | 2017 | 1467 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2018 | 281 | 0.230 |
Why?
|
| Time Factors | 4 | 2020 | 695 | 0.210 |
Why?
|
| Lipoproteins, HDL | 2 | 2022 | 12 | 0.210 |
Why?
|
| Pelvic Floor Disorders | 1 | 2023 | 6 | 0.190 |
Why?
|
| Vascular Stiffness | 2 | 2020 | 4 | 0.190 |
Why?
|
| Sex Offenses | 1 | 2023 | 16 | 0.190 |
Why?
|
| Urinary Incontinence | 1 | 2023 | 15 | 0.190 |
Why?
|
| Complementary Therapies | 1 | 2022 | 2 | 0.190 |
Why?
|
| Testosterone | 2 | 2015 | 12 | 0.180 |
Why?
|
| Waist Circumference | 4 | 2016 | 23 | 0.180 |
Why?
|
| Weather | 1 | 2022 | 5 | 0.180 |
Why?
|
| Age Factors | 4 | 2018 | 350 | 0.180 |
Why?
|
| Family Characteristics | 1 | 2022 | 11 | 0.180 |
Why?
|
| Incidence | 3 | 2021 | 338 | 0.180 |
Why?
|
| Income | 1 | 2022 | 35 | 0.180 |
Why?
|
| Socioeconomic Factors | 3 | 2017 | 153 | 0.180 |
Why?
|
| Poverty | 1 | 2022 | 45 | 0.170 |
Why?
|
| Urban Population | 1 | 2022 | 78 | 0.170 |
Why?
|
| Adipokines | 1 | 2021 | 5 | 0.170 |
Why?
|
| Pandemics | 1 | 2021 | 126 | 0.160 |
Why?
|
| Acute Pain | 1 | 2020 | 9 | 0.160 |
Why?
|
| Pain Measurement | 2 | 2020 | 211 | 0.160 |
Why?
|
| Quality of Life | 1 | 2022 | 261 | 0.160 |
Why?
|
| Ovariectomy | 1 | 2020 | 19 | 0.160 |
Why?
|
| Preoperative Period | 1 | 2020 | 34 | 0.150 |
Why?
|
| Postoperative Period | 1 | 2020 | 118 | 0.150 |
Why?
|
| Body Composition | 1 | 2019 | 43 | 0.150 |
Why?
|
| Aortography | 1 | 2018 | 4 | 0.140 |
Why?
|
| Aortic Diseases | 1 | 2018 | 2 | 0.140 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 13 | 0.140 |
Why?
|
| Absorptiometry, Photon | 3 | 2015 | 62 | 0.140 |
Why?
|
| Laparoscopy | 2 | 2015 | 95 | 0.130 |
Why?
|
| Follicle Stimulating Hormone | 3 | 2020 | 14 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 34 | 0.130 |
Why?
|
| Residence Characteristics | 1 | 2017 | 87 | 0.130 |
Why?
|
| Premenopause | 1 | 2017 | 5 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 546 | 0.120 |
Why?
|
| Beverages | 1 | 2016 | 11 | 0.120 |
Why?
|
| Waist-Height Ratio | 1 | 2016 | 4 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 6 | 0.120 |
Why?
|
| Menstrual Cycle | 2 | 2007 | 15 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2018 | 817 | 0.120 |
Why?
|
| Electrocardiography | 1 | 2016 | 47 | 0.120 |
Why?
|
| Mass Screening | 1 | 2016 | 86 | 0.120 |
Why?
|
| Abdominal Fat | 1 | 2015 | 5 | 0.120 |
Why?
|
| Gastrectomy | 1 | 2015 | 16 | 0.110 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 6 | 0.110 |
Why?
|
| Colectomy | 1 | 2015 | 10 | 0.110 |
Why?
|
| Estradiol | 1 | 2015 | 26 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2015 | 24 | 0.110 |
Why?
|
| Herniorrhaphy | 1 | 2015 | 16 | 0.110 |
Why?
|
| Biomarkers | 2 | 2021 | 294 | 0.110 |
Why?
|
| General Surgery | 1 | 2015 | 18 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 14 | 0.110 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 11 | 0.110 |
Why?
|
| Appendectomy | 1 | 2014 | 8 | 0.110 |
Why?
|
| Meals | 1 | 2014 | 7 | 0.110 |
Why?
|
| Appendicitis | 1 | 2014 | 11 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2015 | 36 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 73 | 0.110 |
Why?
|
| Disease Management | 1 | 2015 | 59 | 0.110 |
Why?
|
| Decision Making | 1 | 2015 | 95 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2014 | 78 | 0.100 |
Why?
|
| Employment | 1 | 2013 | 22 | 0.100 |
Why?
|
| Mexican Americans | 1 | 2013 | 12 | 0.100 |
Why?
|
| Confidence Intervals | 2 | 2015 | 42 | 0.100 |
Why?
|
| Community Health Workers | 1 | 2013 | 19 | 0.100 |
Why?
|
| Morbidity | 2 | 2014 | 33 | 0.100 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2013 | 10 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 195 | 0.090 |
Why?
|
| Body Fat Distribution | 1 | 2012 | 6 | 0.090 |
Why?
|
| Weight Gain | 1 | 2013 | 30 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 82 | 0.090 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2011 | 8 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2018 | 295 | 0.090 |
Why?
|
| Pulsatile Flow | 1 | 2011 | 3 | 0.080 |
Why?
|
| Obesity | 1 | 2013 | 156 | 0.080 |
Why?
|
| Aorta | 1 | 2011 | 7 | 0.080 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2011 | 2 | 0.080 |
Why?
|
| Prejudice | 1 | 2011 | 21 | 0.080 |
Why?
|
| Hydrocortisone | 1 | 2010 | 16 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 218 | 0.080 |
Why?
|
| Aged | 5 | 2019 | 4000 | 0.080 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2021 | 9 | 0.080 |
Why?
|
| Calcium | 1 | 2012 | 288 | 0.070 |
Why?
|
| Pulse Wave Analysis | 2 | 2020 | 4 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2010 | 122 | 0.070 |
Why?
|
| Logistic Models | 3 | 2015 | 196 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2021 | 152 | 0.070 |
Why?
|
| Prognosis | 3 | 2018 | 363 | 0.070 |
Why?
|
| Accidental Falls | 1 | 2008 | 39 | 0.070 |
Why?
|
| Cholesterol, HDL | 2 | 2022 | 13 | 0.070 |
Why?
|
| Postural Balance | 1 | 2008 | 62 | 0.070 |
Why?
|
| Blood Pressure | 3 | 2013 | 99 | 0.060 |
Why?
|
| Estrone | 1 | 2007 | 5 | 0.060 |
Why?
|
| Pregnanediol | 1 | 2007 | 5 | 0.060 |
Why?
|
| Luteinizing Hormone | 1 | 2007 | 6 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2006 | 6 | 0.060 |
Why?
|
| Carotid Arteries | 2 | 2020 | 5 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 110 | 0.060 |
Why?
|
| Gonadal Hormones | 1 | 2005 | 2 | 0.060 |
Why?
|
| Male | 5 | 2015 | 6815 | 0.060 |
Why?
|
| Survival Rate | 2 | 2015 | 152 | 0.050 |
Why?
|
| Telomerase | 1 | 2003 | 2 | 0.050 |
Why?
|
| K562 Cells | 1 | 2003 | 4 | 0.050 |
Why?
|
| Histones | 1 | 2003 | 13 | 0.050 |
Why?
|
| Pelvic Floor | 1 | 2023 | 7 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2022 | 16 | 0.050 |
Why?
|
| Benchmarking | 1 | 2022 | 13 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2013 | 132 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2011 | 53 | 0.040 |
Why?
|
| Hot Flashes | 1 | 2020 | 4 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2015 | 1478 | 0.040 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 58 | 0.040 |
Why?
|
| Femoral Artery | 1 | 2020 | 4 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 423 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2019 | 20 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 134 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 191 | 0.030 |
Why?
|
| Tomography | 1 | 2018 | 6 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 229 | 0.030 |
Why?
|
| Pericardium | 1 | 2017 | 12 | 0.030 |
Why?
|
| Energy Intake | 1 | 2016 | 46 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 175 | 0.030 |
Why?
|
| Climacteric | 1 | 2015 | 4 | 0.030 |
Why?
|
| Hernia, Umbilical | 1 | 2015 | 3 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2015 | 99 | 0.030 |
Why?
|
| Hernia, Inguinal | 1 | 2015 | 15 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2015 | 24 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 28 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 15 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 156 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 38 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 258 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 97 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 110 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 168 | 0.030 |
Why?
|
| Hypertension | 1 | 2014 | 85 | 0.030 |
Why?
|
| Length of Stay | 1 | 2014 | 126 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2013 | 46 | 0.020 |
Why?
|
| Community Health Services | 1 | 2013 | 19 | 0.020 |
Why?
|
| Self Care | 1 | 2013 | 53 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2013 | 75 | 0.020 |
Why?
|
| Polysomnography | 1 | 2013 | 39 | 0.020 |
Why?
|
| Actigraphy | 1 | 2013 | 41 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 103 | 0.020 |
Why?
|
| Overweight | 1 | 2013 | 35 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2011 | 8 | 0.020 |
Why?
|
| Elasticity | 1 | 2011 | 19 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2011 | 16 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2011 | 6 | 0.020 |
Why?
|
| Triglycerides | 1 | 2011 | 24 | 0.020 |
Why?
|
| Chicago | 1 | 2012 | 453 | 0.020 |
Why?
|
| Insulin | 1 | 2011 | 41 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 115 | 0.020 |
Why?
|
| Saliva | 1 | 2010 | 24 | 0.020 |
Why?
|
| Torque | 1 | 2008 | 8 | 0.020 |
Why?
|
| Rotation | 1 | 2008 | 54 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2008 | 96 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2007 | 11 | 0.020 |
Why?
|
| Aromatase | 1 | 2006 | 1 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 1 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2006 | 1 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2006 | 1 | 0.020 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2006 | 2 | 0.020 |
Why?
|
| Health Surveys | 1 | 2006 | 38 | 0.020 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2005 | 3 | 0.010 |
Why?
|
| Perimenopause | 1 | 2005 | 7 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 141 | 0.010 |
Why?
|
| Karyotyping | 1 | 2003 | 7 | 0.010 |
Why?
|
| Granulocytes | 1 | 2003 | 6 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2003 | 12 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 30 | 0.010 |
Why?
|
| Remission Induction | 1 | 2003 | 45 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 57 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2003 | 35 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 2152 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 90 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 157 | 0.010 |
Why?
|